Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nivalis Therapeutics Inc (NASDAQ:NVLS)

8.38
Delayed Data
As of Sep 23
 -0.28 / -3.23%
Today’s Change
3.68
Today|||52-Week Range
16.08
+8.27%
Year-to-Date

Today’s Trading

Previous close8.66
Today’s open8.59
Day’s range8.01 - 8.63
Volume158,509
Average volume (3 months)63,391
Market cap$129.9M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-156.17%
Earnings growth (this year)+5.93%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.55

Competitors

 Today’s
change
Today’s
% change
ADHDAlcobra Ltd-0.05-1.06%
ANTHAnthera Pharmaceutic...+0.05+1.59%
ECYTEndocyte Inc-0.01-0.32%
TTNPTitan Pharmaceutical...-0.05-0.83%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateOctober 31, 2016
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$0.00
Annual profit (last year)-$22.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon Congleton
Chief Operating Officer
Janice Troha
Corporate headquarters
Boulder, Colorado

Forecasts

Search for Jobs